- Home
- SBFM vs TRIB Comparison
SBFM vs TRIB Comparison
Compare SBFM & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- TRIB
- Stock Information
- Founded
- SBFM 2006
- TRIB 1992
- Country
- SBFM United States
- TRIB Ireland
- Employees
- SBFM N/A
- TRIB N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SBFM Health Care
- TRIB Health Care
- Exchange
- SBFM Nasdaq
- TRIB Nasdaq
- Market Cap
- SBFM 6.7M
- TRIB 5.4M
- IPO Year
- SBFM N/A
- TRIB N/A
- Fundamental
- Price
- SBFM $1.67
- TRIB $1.07
- Analyst Decision
- SBFM Strong Buy
- TRIB
- Analyst Count
- SBFM 1
- TRIB 0
- Target Price
- SBFM $15.00
- TRIB N/A
- AVG Volume (30 Days)
- SBFM 62.2K
- TRIB 109.3K
- Earning Date
- SBFM 11-04-2025
- TRIB 11-14-2025
- Dividend Yield
- SBFM N/A
- TRIB N/A
- EPS Growth
- SBFM N/A
- TRIB N/A
- EPS
- SBFM N/A
- TRIB N/A
- Revenue
- SBFM $36,341,741.00
- TRIB $61,555,000.00
- Revenue This Year
- SBFM $32.20
- TRIB $13.51
- Revenue Next Year
- SBFM $32.74
- TRIB $13.14
- P/E Ratio
- SBFM N/A
- TRIB N/A
- Revenue Growth
- SBFM 19.22
- TRIB 8.31
- 52 Week Low
- SBFM $1.17
- TRIB $0.48
- 52 Week High
- SBFM $3.90
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- SBFM 67.82
- TRIB 44.32
- Support Level
- SBFM $1.50
- TRIB $1.00
- Resistance Level
- SBFM $1.67
- TRIB $1.17
- Average True Range (ATR)
- SBFM 0.08
- TRIB 0.07
- MACD
- SBFM 0.01
- TRIB -0.01
- Stochastic Oscillator
- SBFM 73.44
- TRIB 27.96
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.